Ilya Yuffa

EVP&Pres, LLY USA&Global Capab

Ilya Yuffa (EVP&Pres, LLY USA&Global Capab) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Eli Lilly and Company (LLY). The largest single filing was $2.9M of LLY (2,500 sh × $1,150.77, as filed), executed Jun 10.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.9M

shares × price, as filed

Last traded

Jun 10

Filed Jun 11

Median ADV $3.8B across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

LLY

Eli Lilly and Company LLY · 0 buys · 3 sells 3 filings

Recent filings

LLYSALE Eli Lilly and Company View filing → $2.9M
2,500 sh × $1,150.77
Exec Jun 10
Filed Jun 11 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $784K
1,250 sh × $627.01
Exec Aug 11 2025
Filed Aug 12 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $937K
1,250 sh × $749.24
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET